demonstrated that claudin-4 is a potent inhibitor of the aggressive and metastatic phenotype of PCa cells and a target of transforming growth factor (TGF)-β and the Ras/Raf/Erk pathway. This evidence concerns the gene CLDN4 and posterior cortical atrophy.